{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T21:49:50Z","timestamp":1755035390397,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00134-023-07063-2","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T03:30:33Z","timestamp":1682566233000},"page":"656-658","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Severe community-acquired pneumonia: in search of the guiding star"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7069-7304","authenticated-orcid":false,"given":"Pedro","family":"P\u00f3voa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad","family":"Nseir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Salluh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"7063_CR1","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1007\/S00134-020-06296-9","volume":"46","author":"MA Matthay","year":"2020","unstructured":"Matthay MA, Arabi YM, Siegel ER et al (2020) Phenotypes and personalized medicine in the acute respiratory distress syndrome. Intensive Care Med 46:2136\u20132152. https:\/\/doi.org\/10.1007\/S00134-020-06296-9","journal-title":"Intensive Care Med"},{"key":"7063_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM et al (2020) Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. Lancet (London, England) 395:200\u2013211. https:\/\/doi.org\/10.1016\/S0140-6736(19)32989-7","journal-title":"Lancet (London, England)"},{"key":"7063_CR3","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1164\/AJRCCM\/148.5.1418","volume":"148","author":"MS Niederman","year":"1993","unstructured":"Niederman MS, Bass JB, Campbell GD et al (1993) Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 148:1418\u20131426. https:\/\/doi.org\/10.1164\/AJRCCM\/148.5.1418","journal-title":"Am Rev Respir Dis"},{"key":"7063_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-023-07033-8","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches I, Torres A, Nagavci B, et al (2023) ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-023-07033-8","journal-title":"Intensive Care Med"},{"key":"7063_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMOA1500245","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink RG et al (2015) Community-acquired pneumonia requiring hospitalization among U.S. Adults N Engl J Med 373:415\u2013427. https:\/\/doi.org\/10.1056\/NEJMOA1500245","journal-title":"Adults N Engl J Med"},{"key":"7063_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000479089","volume":"94","author":"J Almirall","year":"2017","unstructured":"Almirall J, Serra-Prat M, Bol\u00edbar I, Balasso V (2017) Risk factors for community-acquired pneumonia in adults: a systematic review of observational studies. Respiration 94:299\u2013311. https:\/\/doi.org\/10.1159\/000479089","journal-title":"Respiration"},{"key":"7063_CR7","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/THORAXJNL-2014-206744","volume":"70","author":"M Kolditz","year":"2015","unstructured":"Kolditz M, Ewig S, Klapdor B et al (2015) Community-acquired pneumonia as medical emergency: predictors of early deterioration. Thorax 70:551\u2013558. https:\/\/doi.org\/10.1136\/THORAXJNL-2014-206744","journal-title":"Thorax"},{"key":"7063_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0191721","author":"M Ferrer","year":"2018","unstructured":"Ferrer M, Travierso C, Cilloniz C et al (2018) Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients. PLoS ONE. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0191721","journal-title":"PLoS ONE"},{"key":"7063_CR9","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/S00134-022-06684-3","volume":"48","author":"GU Meduri","year":"2022","unstructured":"Meduri GU, Shih MC, Bridges L et al (2022) Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Med 48:1009\u20131023. https:\/\/doi.org\/10.1007\/S00134-022-06684-3","journal-title":"Intensive Care Med"},{"key":"7063_CR10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2215145","author":"P-F Dequin","year":"2023","unstructured":"Dequin P-F, Meziani F, Quenot J-P et al (2023) Hydrocortisone in severe community-acquired pneumonia. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMOA2215145","journal-title":"N Engl J Med"},{"key":"7063_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/QCO.0000000000000709","volume":"34","author":"P P\u00f3voa","year":"2021","unstructured":"P\u00f3voa P, Coelho L, Salluh J (2021) When should we use corticosteroids in severe community-acquired pneumonia? Curr Opin Infect Dis 34:169\u2013174. https:\/\/doi.org\/10.1097\/QCO.0000000000000709","journal-title":"Curr Opin Infect Dis"},{"key":"7063_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/S00134-022-06956-Y","author":"P P\u00f3voa","year":"2023","unstructured":"P\u00f3voa P, Coelho L, Dal-Pizzol F et al (2023) How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive Care Med. https:\/\/doi.org\/10.1007\/S00134-022-06956-Y","journal-title":"Intensive Care Med"},{"key":"7063_CR13","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S2213-2600(22)00086-8","volume":"10","author":"AM Darie","year":"2022","unstructured":"Darie AM, Khanna N, Jahn K et al (2022) Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial. Lancet Respir Med 10:877\u2013887. https:\/\/doi.org\/10.1016\/S2213-2600(22)00086-8","journal-title":"Lancet Respir Med"},{"key":"7063_CR14","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1097\/CCM.0000000000002525","volume":"45","author":"JB Lascarrou","year":"2017","unstructured":"Lascarrou JB, Lissonde F, Le Thuaut A et al (2017) Antibiotic therapy in comatose mechanically ventilated patients following aspiration: Differentiating pneumonia from pneumonitis. Crit Care Med 45:1268\u20131275. https:\/\/doi.org\/10.1097\/CCM.0000000000002525","journal-title":"Crit Care Med"},{"key":"7063_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/QCO.0B013E32835EBC6D","volume":"26","author":"MI Restrepo","year":"2013","unstructured":"Restrepo MI, Faverio P, Anzueto A (2013) Long-term prognosis in community-acquired pneumonia. Curr Opin Infect Dis 26:151\u2013158. https:\/\/doi.org\/10.1097\/QCO.0B013E32835EBC6D","journal-title":"Curr Opin Infect Dis"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-023-07063-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-023-07063-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-023-07063-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T09:05:13Z","timestamp":1687511113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-023-07063-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["7063"],"URL":"https:\/\/doi.org\/10.1007\/s00134-023-07063-2","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"type":"print","value":"0342-4642"},{"type":"electronic","value":"1432-1238"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"assertion":[{"value":"27 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PP received honoraria for lectures and advisory boards from Abionic, Merck Sharp & Dohme, Sanofi, Gilead, Mundipharma and Pfizer; SN received honoraria for lectures and DSMB from Pfizer, Gilead, MSD, Biomerieux, Bio Rad, Fisher and Paykel; JS has nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}